Lakefront Biotherapeutics | GLPG - Przychody Ze Sprzedaży





Obroty Zmiana Data
argenx SE USD 1.12B 0 2026-03
AstraZeneca USD 15.29B 213M 2026-03
Biogen USD 2.25B 30M 2026-03
Genmab DKK 1.06B 36M 2025-12
Gilead Sciences USD 7B 930M 2026-03
GlaxoSmithKline GBP 7.63B 991M 2026-03
GRIFOLS EUR 1.7B 280M 2026-03
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Incyte USD 1.27B 240M 2026-03
Merck EUR 5.13B 120M 2026-03
Neurocrine Biosciences USD 811M 5.5M 2026-03
Novartis USD 13.11B 226M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.24B 60M 2026-03
UCB EUR 4.25B 764M 2025-12
Vertex Pharmaceuticals USD 2.99B 200M 2026-03